Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (11-20 of 460) with videos related to

Pageof 46
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2018
Predicting Dangerous Rides in CAR T Cells: Bridging the Gap between Mice and HumansMarco Ruella, Carl H June
Immunity|November 16, 2024
CAR T cells in autoimmune disease: On the road to remissionGeorg Schett, Carl H June
Nature Biotechnology|November 12, 2024
Beyond the blood: expanding CAR T cell therapy to solid tumorsUgur Uslu, Carl H June
Cancer Immunology Research|June 22, 2023
T-cell Therapies Targeting Multiple Cancer Antigens: The Power of ManyUgur Uslu, Carl H June
Blood Cancer Discovery|July 27, 2022
CAR T-cell Therapy Meets Clonal HematopoiesisUgur Uslu, Carl H June
The New England Journal of Medicine|July 5, 2018
Chimeric Antigen Receptor TherapyCarl H June, Michel Sadelain
Current Hematologic Malignancy Reports|August 1, 2016
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for YouMarco Ruella, Carl H June
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
From bench to bloodstream: Lipid nanoparticles drive on-demand CAR-T cellsCarl H June, Haig Aghajanian
Immunity|July 30, 2013
Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biologyMichael Kalos, Carl H June
Blood Cancer Discovery|May 7, 2024
CAR T-cell Resistance to Oncogenic TransformationMarco Ruella, Carl H June
Pageof 46

Showing results (11-20 of 460) with videos related to

Sort By:
Pageof 46
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2018
Predicting Dangerous Rides in CAR T Cells: Bridging the Gap between Mice and HumansMarco Ruella, Carl H June
Immunity|November 16, 2024
CAR T cells in autoimmune disease: On the road to remissionGeorg Schett, Carl H June
Nature Biotechnology|November 12, 2024
Beyond the blood: expanding CAR T cell therapy to solid tumorsUgur Uslu, Carl H June
Cancer Immunology Research|June 22, 2023
T-cell Therapies Targeting Multiple Cancer Antigens: The Power of ManyUgur Uslu, Carl H June
Blood Cancer Discovery|July 27, 2022
CAR T-cell Therapy Meets Clonal HematopoiesisUgur Uslu, Carl H June
The New England Journal of Medicine|July 5, 2018
Chimeric Antigen Receptor TherapyCarl H June, Michel Sadelain
Current Hematologic Malignancy Reports|August 1, 2016
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for YouMarco Ruella, Carl H June
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
From bench to bloodstream: Lipid nanoparticles drive on-demand CAR-T cellsCarl H June, Haig Aghajanian
Immunity|July 30, 2013
Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biologyMichael Kalos, Carl H June
Blood Cancer Discovery|May 7, 2024
CAR T-cell Resistance to Oncogenic TransformationMarco Ruella, Carl H June
Pageof 46